Baseline asthma group(n = 40) | Baseline treatment subgroup(n = 18) | Post-treatment treatment subgroup(n = 18) | ||||
---|---|---|---|---|---|---|

r | p Value | r | p Value | r | p Value | |

FEV_{1}, forced expiratory volume in 1 s; Fe_{NO}, fraction of nitric oxide in exhaled breath; FVC, forced vital capacity; LCI, lung clearance index; S_{cond}, ventilation heterogeneity in conducting airways; S_{acin}, ventilation heterogeneity in acinar lung zone | ||||||

Airway inflammation (FE_{NO}) | 0.62 | <0.001 | 0.51 | 0.03 | 0.61 | 0.008 |

Ventilation heterogeneity (S_{cond}) | 0.63 | <0.001 | 0.64 | 0.004 | 0.82 | <0.001 |

Ventilation heterogeneity (S_{acin}) | 0.07 | 0.67 | 0.04 | 0.86 | −0.02 | 0.93 |

Ventilation heterogeneity (LCI) | 0.38 | 0.02 | 0.31 | 0.21 | 0.47 | 0.05 |

FEV_{1} % predicted | −0.44 | 0.005 | −0.40 | 0.10 | −0.37 | 0.13 |

FEV_{1}/FVC ratio | −0.47 | 0.002 | −0.34 | 0.17 | −0.21 | 0.41 |